Roles of FGF receptors in mammalian development and congenital diseases
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Four fibroblast growth factor receptors (FGFR1–4) constitute a family of transmembrane tyrosine kinases that serve as high affinity receptors for at least 22 FGF ligands. Gene targeting in mice has yielded valuable insights into the functions of this important gene family in multiple biological processes. These include mesoderm induction and patterning; cell growth, migration, and differentiation; organ formation and maintenance; neuronal differentiation and survival; wound healing; and malignant transformation. Furthermore, discoveries that mutations in three of the four receptors result in more than a dozen human congenital diseases highlight the importance of these genes in skeletal development. In this review, we will discuss recent progress on the roles of FGF receptors in mammalian development and congenital diseases, with an emphasis on signal transduction pathways. Birth Defects Research (Part C) 69:286–304, 2003. Published 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
The origins, patterns and implications of human spontaneous mutation
Crow, J. F. (2000) · Nature Reviews Genetics · doi:10.1038/35049558 · Cited by 928 · cited 1×
“Interestingly, mutation rates in some FGFR2 and FGFR3 associated craniosynostoses appear higher in male than female gametes and often increase with paternal age (Crow, 2000; Li et al., 2002).”
BackgroundChesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637 · cited 1×
“Translocation of the immunoglobulin heavy chain locus at chromosome 14q32 close to the FGFR3 gene (50-120 kb centromeric) in myeloma is a common process (Chesi et al., 1997; Richelda et al., 1997).”
BackgroundSpatial and temporal patterns of ERK signaling during mouse embryogenesis
Corson, L. B., Yamanaka, Y., Lai, K.-M. V., & Rossant, J. (2003) · Development · doi:10.1242/dev.00669 · Cited by 390 · cited 1×
“Furthermore, a brief incubation with an inhibitor of FGF receptor specifically decreased the phospho-ERK staining (Corson et al., 2003).”
BackgroundManagement of craniosynostoses
Renier, D., Lajeunie, E., Arnaud, E., & Marchac, D. (2000) · Child s Nervous System · doi:10.1007/s003810000320 · Cited by 384
Iseki, S., Wilkie, A. O. M., & Morriss-Kay, G. M. (1999) · Development · doi:10.1242/dev.126.24.5611 · Cited by 305
Fibroblast Growth Factors In The Developing Central Nervous System
Ford‐Perriss, M., Abud, H., & Murphy, M. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03477.x · Cited by 264 · cited 1×
“The four FGFRs are expressed in the CNS with FGF2, 8, 15 and 17 among their most important ligands (Ford-Perriss et al., 2001).”
BackgroundRegulation of FGF receptors in the oligodendrocyte lineage
Bansal, R., Kumar, M., Murray, K., Morrison, R. S., & Pfeiffer, S. E. (1996) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1996.0020 · Cited by 160
Cited by
Functions of heparan sulfate proteoglycans in cell signaling during development
Lin, X. (2004) · Development · doi:10.1242/dev.01522 · Cited by 678
Functions and regulations of fibroblast growth factor signaling during embryonic development
Thisse, B., & Thisse, C. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.09.011 · Cited by 497
Fibroblast growth factor (FGF) signaling in development and skeletal diseases
Teven, C. M., Farina, E. M., Rivas, J., & Reid, R. R. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.09.005 · Cited by 237
Zhao, M., Li, D., Shimazu, K., Zhou, Y.-X., Lu, B., & Deng, C.-X. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.019 · Cited by 171
Self-citationRai, K. S., Hattiangady, B., & Shetty, A. K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05820.x · Cited by 144
“The mammalian FGF receptor family (FGFR) consists of a group of four trans-membrane proteins (FGFR1– FGFR4) with intrinsic tyrosine kinase activity (Coumoul & Deng, 2003; Zhao et al., 2007).”
BackgroundRole and Mechanisms of Actions of Thyroid Hormone on the Skeletal Development
Kim, H.-Y., & Mohan, S. (2013) · Bone Research · doi:10.4248/br201302004 · Cited by 117
Thyroid Hormones Regulate Fibroblast Growth Factor Receptor Signaling during Chondrogenesis
Barnard, J. C., Williams, A. J., Rabier, B., Chassande, O., Samarut, J., Cheng, S.-Y., Bassett, J. H. D., & Williams, G. R. (2005) · Endocrinology · doi:10.1210/en.2005-0762 · Cited by 85
Kadam, S., McMahon, A., Tzou, P., & Stathopoulos, A. (2009) · Development · doi:10.1242/dev.027904 · Cited by 83
“Later functions include organ formation and maintenance, neuronal differentiation and survival, wound healing and malignant transformation (Chen and Deng, 2005; Coumoul and Deng, 2003; Eswarakumar et al., 2005).”
BackgroundHisaoka, K., Tsuchioka, M., Yano, R., Maeda, N., Kajitani, N., Morioka, N., Nakata, Y., & Takebayashi, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224683 · Cited by 57
Metadata
- Authors
- Coumoul, X., & Deng, C.
- Venue
- Birth Defects Research Part C: Embryo Today: Reviews
- Publisher
- Wiley
- Published
- 2003-12
- Volume
- 69
- Issue
- 4
- Pages
- 286-304
- ISSN
- 1542-975X (ISSN-L)
- 1542-9768
- OpenAlex
- W2069064984
- Cited by
- 121
- References
- 8
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.